Remediation of Mild, Acute Radiation Dermatitis Using a Stem Cell-Based Topical: A Real-World Case Report.

Area of Science:

• Regenerative Medicine
• Dermatology
• Oncology Supportive Care

Background:

• Radiation therapy can cause skin damage, including radiation dermatitis, disrupting skin homeostasis and increasing inflammation.
• Current treatments for severe radiation dermatitis show promise, but mild forms require further investigation.
• Stem cell-derived molecules offer potential for physiological renormalization of skin conditions.

Observation:

• A case report details the use of S2RM technology (stem cell-released molecules) to treat mild radiation dermatitis in a patient with cutaneous basosquamous cell carcinoma.
• The patient underwent Intensity Modulated Radiation Therapy, leading to mild radiation dermatitis.
• S2RM technology aims to restore skin homeostasis and proteostasis.

Findings:

• Topical application of S2RM technology resulted in dramatic reductions in pain, redness, and inflammation.
• The treatment promoted more rapid and complete wound healing.
• Overall skin appearance was significantly enhanced.

Implications:

• S2RM technology presents a powerful, simple topical application for remediating mild radiation dermatitis.
• This approach can be integrated into palliative care strategies for cancer patients.
• Reducing skin inflammation may help mitigate systemic inflammation and associated comorbidities.